Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-22

FDA Approved: LATANOPROST — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approves the generic latanoprost (Sandoz) under Original Application (ANDA). The product is indicated for reduction of elevated intraocular pressure in open…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

ORIG AP for LATANOPROST (LATANOPROST)